Literature DB >> 11767276

Actinobacillus actinomycetemcomitans-induced expression of IL-1alpha and IL-1beta in human gingival epithelial cells: role in IL-8 expression.

A Sfakianakis1, C E Barr, D L Kreutzer.   

Abstract

Gingival epithelial cells (GEC) are the first cells of the host that encounter the periodontal pathogens. and therefore their role in the initiation of the inflammatory response is critical. We aimed to: 1) characterize the expression of interleukin (IL)- Ialpha and IL-Ibeta in human gingiva and cultured GEC: 2) demonstrate the ability of A. actinomycetemcomitans extracts to upregulate IL-1alpha, IL-1beta and IL-8 expression in GEC in vitro: and 3) characterize the role of IL-1alpha and IL-1beta in the induction of IL-8 expression in GEC in vitro. Ten gingival biopsies (5 inflamed and 5 controls) and cultured GEC were examined for IL-1alpha and IL-Ibeta using immunohistochemical techniques. GEC were also challenged with A. actinomycetemcomitans extracts or IL-1alpha, and secretion of IL-1 and IL-8 was determined by ELISA. In vivo, IL-lalpha and IL-1beta were localized in the gingival epithelium and the infiltrating leukocytes. In vitro, A. actinomycetemcomitans extracts induced a time-dependent expression of IL-1alpha, IL-1beta and IL-8 in GEC. IL-1 inhibitors did not affect A. actinomycetemcomitans-induced IL-8. although they inhibited IL-8 induced by IL-1alpha or IL-1beta. In conclusion, GEC are a major source of IL-1alpha and IL-1beta in the periodontium, which in turn induce additional inflammatory mediators such as IL-8. Therefore GEC can be a potential target for therapeutic intervention in the future.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11767276     DOI: 10.1034/j.1600-0722.2001.00162.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  8 in total

1.  Upregulation of intercellular adhesion molecule 1 and proinflammatory cytokines by the major surface proteins of Treponema maltophilum and Treponema lecithinolyticum, the phylogenetic group IV oral spirochetes associated with periodontitis and endodontic infections.

Authors:  Sung-Hoon Lee; Kack-Kyun Kim; Bong-Kyu Choi
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  IL-1β strengthens the physical barrier in gingival epithelial cells.

Authors:  Kim Natalie Stolte; Carsten Pelz; Cynthia V Yapto; Jan-Dirk Raguse; Henrik Dommisch; Kerstin Danker
Journal:  Tissue Barriers       Date:  2020-08-23

3.  Constitutive release of cytokines by human oral keratinocytes in an organotypic culture.

Authors:  Qin Xu; Kenji Izumi; Takayoshi Tobita; Yoshitaka Nakanishi; Stephen E Feinberg
Journal:  J Oral Maxillofac Surg       Date:  2009-06       Impact factor: 1.895

4.  Immunolocalization of CXC chemokine and recruitment of polymorphonuclear leukocytes in the rat molar periodontal tissue after topical application of lipopolysaccharide.

Authors:  Mutsumi Miyauchi; Shoji Kitagawa; Masae Hiraoka; Akihisa Saito; Sunao Sato; Yasusei Kudo; Ikuko Ogawa; Takashi Takata
Journal:  Histochem Cell Biol       Date:  2004-03-24       Impact factor: 4.304

Review 5.  Animal models for periodontal disease.

Authors:  Helieh S Oz; David A Puleo
Journal:  J Biomed Biotechnol       Date:  2011-02-10

6.  Oral microbe-host interactions: influence of β-glucans on gene expression of inflammatory cytokines and metabolome profile.

Authors:  Viviam de Oliveira Silva; Luciano José Pereira; Ramiro Mendonça Murata
Journal:  BMC Microbiol       Date:  2017-03-07       Impact factor: 3.605

7.  Distinct Signaling Pathways Between Human Macrophages and Primary Gingival Epithelial Cells by Aggregatibacter actinomycetemcomitans.

Authors:  Ellen S Ando-Suguimoto; Manjunatha R Benakanakere; Marcia P A Mayer; Denis F Kinane
Journal:  Pathogens       Date:  2020-03-27

8.  Expression of Interleukin-1ß and Interleukin-8 in Oral Potentially Malignant Disorders and Carcinomas.

Authors:  Jeaneth Lopez-Labady; Ronell Bologna-Molina; Mariana Villarroel-Dorrego
Journal:  Front Oral Health       Date:  2021-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.